These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34372561)

  • 1. Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama.
    Rojas-Bonilla M; Coulliette-Salmond A; Belgasmi H; Wong K; Sayyad L; Vega E; Grimoldi F; Oberste MS; Rüttimann R
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
    Martin J; Burns CC; Jorba J; Shulman LM; Macadam A; Klapsa D; Majumdar M; Bullows J; Frolov A; Mate R; Bujaki E; Castro CJ; Bullard K; Konz J; Hawes K; Gauld J; Blake IM; Mercer LD; Kurji F; Voorman A; Diop OM; Oberste MS; Modlin J; Macklin G; Eisenhawer M; Bandyopadhyay AS; Zipursky S
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(24):786-790. PubMed ID: 35709073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.
    Battistone A; Buttinelli G; Fiore S; Amato C; Bonomo P; Patti AM; Vulcano A; Barbi M; Binda S; Pellegrinelli L; Tanzi ML; Affanni P; Castiglia P; Germinario C; Mercurio P; Cicala A; Triassi M; Pennino F; Fiore L
    Appl Environ Microbiol; 2014 Aug; 80(15):4491-501. PubMed ID: 24814793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
    Van Damme P; De Coster I; Bandyopadhyay AS; Revets H; Withanage K; De Smedt P; Suykens L; Oberste MS; Weldon WC; Costa-Clemens SA; Clemens R; Modlin J; Weiner AJ; Macadam AJ; Andino R; Kew OM; Konopka-Anstadt JL; Burns CC; Konz J; Wahid R; Gast C
    Lancet; 2019 Jul; 394(10193):148-158. PubMed ID: 31174831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Surveillance Complements Case-Based Surveillance of Acute Flaccid Paralysis in Polio Endgame Strategy 2019-2023.
    Chen P; Liu Y; Wang H; Liu G; Lin X; Zhang W; Ji F; Xu Q; Tao Z; Xu A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32444474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
    Wahid R; Mercer LD; De Leon T; DeAntonio R; Sáez-Llorens X; Macadam A; Chumakov K; Strating J; Koel B; Konopka-Anstadt JL; Oberste MS; Burns CC; Andino R; Tritama E; Bandyopadhyay AS; Aguirre G; Rüttimann R; Gast C; Konz JO
    Lancet Microbe; 2022 Dec; 3(12):e912-e921. PubMed ID: 36332645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing a robust adverse event of special interest surveillance for novel oral polio vaccine type 2 rollout, Nigeria, March-July 2021.
    Abbott SL; Etapelong SG; Gidado S; Mawashi KY; Edukugho AA; Hamisu AW; Shehu A; Adedire E; Hassan IA; Waziri NE; Bolu O; Adamu US
    Pan Afr Med J; 2023; 45(Suppl 2):6. PubMed ID: 38370101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
    Blake IM; Pons-Salort M; Molodecky NA; Diop OM; Chenoweth P; Bandyopadhyay AS; Zaffran M; Sutter RW; Grassly NC
    N Engl J Med; 2018 Aug; 379(9):834-845. PubMed ID: 30157398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
    Sáez-Llorens X; Bandyopadhyay AS; Gast C; Leon T; DeAntonio R; Jimeno J; Caballero MI; Aguirre G; Oberste MS; Weldon WC; Konopka-Anstadt JL; Modlin J; Bachtiar NS; Fix A; Konz J; Clemens R; Costa Clemens SA; Rüttimann R
    Lancet; 2021 Jan; 397(10268):27-38. PubMed ID: 33308427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013).
    Ndiaye AK; Diop PA; Diop OM
    Pan Afr Med J; 2014; 19():243. PubMed ID: 25848458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
    De Coster I; Leroux-Roels I; Bandyopadhyay AS; Gast C; Withanage K; Steenackers K; De Smedt P; Aerssens A; Leroux-Roels G; Oberste MS; Konopka-Anstadt JL; Weldon WC; Fix A; Konz J; Wahid R; Modlin J; Clemens R; Costa Clemens SA; Bachtiar NS; Van Damme P
    Lancet; 2021 Jan; 397(10268):39-50. PubMed ID: 33308429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus and Other Enteroviruses from Environmental Surveillance in Italy, 2009-2015.
    Delogu R; Battistone A; Buttinelli G; Fiore S; Fontana S; Amato C; Cristiano K; Gamper S; Simeoni J; Frate R; Pellegrinelli L; Binda S; Veronesi L; Zoni R; Castiglia P; Cossu A; Triassi M; Pennino F; Germinario C; Balena V; Cicala A; Mercurio P; Fiore L; Pini C; Stefanelli P
    Food Environ Virol; 2018 Dec; 10(4):333-342. PubMed ID: 29948963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Surveillance for Polioviruses in Haïti (2017-2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites.
    Alleman MM; Coulliette-Salmond AD; Wilnique P; Belgasmi-Wright H; Sayyad L; Wong K; Gue E; Barrais R; Rey-Benito G; Burns CC; Vega E
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33803868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliovirus vaccine strains in sewage and river water in South Africa.
    Pavlov DN
    Can J Microbiol; 2006 Aug; 52(8):717-23. PubMed ID: 16917529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haiti Poliovirus Environmental Surveillance.
    Coulliette-Salmond AD; Alleman MM; Wilnique P; Rey-Benito G; Wright HB; Hecker JW; Miles S; Peñaranda S; Lafontant D; Corvil S; Francois J; Rossignol E; Stanislas M; Gue E; Faye PC; Castro CJ; Schmidt A; Ng TFF; Burns CC; Vega E
    Am J Trop Med Hyg; 2019 Dec; 101(6):1240-1248. PubMed ID: 31701857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
    Macklin GR; Peak C; Eisenhawer M; Kurji F; Mach O; Konz J; Gast C; Bachtiar NS; Bandyopadhyay AS; Zipursky S;
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A122-A127. PubMed ID: 35307230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the bag-mediated filtration system for environmental surveillance of poliovirus in Nairobi, Kenya.
    Fagnant-Sperati CS; Ren Y; Zhou NA; Komen E; Mwangi B; Hassan J; Chepkurui A; Nzunza R; Nyangao J; van Zyl WB; Wolfaardt M; Matsapola PN; Ngwana FB; Jeffries-Miles S; Coulliette-Salmond A; Peñaranda S; Vega E; Shirai JH; Kossik AL; Beck NK; Boyle DS; Burns CC; Taylor MB; Borus P; Meschke JS
    J Appl Microbiol; 2021 Mar; 130(3):971-981. PubMed ID: 32743931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.